Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

Want to invest ethically for a brighter future?
(but still make lots of money)?

Want to invest ethically for a brighter future? (but still make lots of money)?

 Take Rask’s FREE Ethical Investing course today.

  • Online & 100% free
  • ETFs, shares & Super
Want to invest ethically for a brighter future? 
(but still make lots of money)?

 Take Rask’s FREE online Ethical Investing course.

Is Douugh Ltd (ASX:DOU) a “Doh!” or a new market darling?

Douugh Limited (ASX: DOU) is one of the only neobanks listed on a stock exchange.

Douugh is deluding a ‘financial wellness’ app that leverages artificial intelligence and software-as-a-service banking systems to automate finance for its users.

A pre-revenue listing

Douugh went public and listed on the ASX through a reverse takeover listing in October 2020. Douugh took over the failed Australian telco ZipTel (ASX: ZIP) and used its ASX listing as a way to become publicly traded.

The listing raised $6 million for Douugh, allowing them to accelerate its launch to market of a ‘financial wellness’ app.

At the time of writing, Douugh is still pre-revenue and has yet to publish their app to the App Store.

A recent ASX announcement from Douugh said they had launched the app in the U.S. after completing beta testing.

How to value Douugh shares

Rask Media writer Patrick Melville looked into Douugh shares in October and tried to value the business. Patrick pointed out that company is almost impossible to value as it ‘makes no money’.

Douugh raised capital and listed at $0.03 per share, and as Patrick points out this is the price that institutions valued Douugh at. At the time of publishing, Douugh trades at $0.35 per share.

From listing til today, Douugh has still not received any revenue. So what justifies this 10 times increase in share price?

Speculation.

Douugh is a speculative share that is pre-revenue, pre-profit and, until yesterday, was pre-product. Investors are buying into the possibility that Douugh will generate money in the future to justify its share price today. Investors are hoping that by getting in early that they will capture future growth.

Would I be buying Douugh shares today?

One of the Rask Investment Philosophies is to invest in companies with ‘strong competitive advantages or moats’ and shares that are ‘reasonably valued’.

When I look at Douugh through this lens, it fails on both philosophies. Douugh does not have a strong competitive advantage or any advantage over the competition in finance apps, neobanks, or traditional banks. This is because there is currently no Douugh product, with no users, and no revenue. In otherwise, no moat.

Douugh is also pre-revenue, so using just about any valuation tool the share price for Douugh should be essentially zero. The value of the company is essentially its book value, which as reported on its balance sheet is around $6.5 million.

With Douugh currently trading with a market cap of $106 million. I would say Douugh is not reasonably valued and instead heavily over valued.

I would not be looking to buy Douugh shares today, maybe after they start to generate revenue I will take another look at the shares. You’ll find more ASX growth shares on Rask Media.

1 ASX Stock to Buy RIGHT NOW...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, Jden does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: